IPP Bureau
AstraZeneca to leverage its capabilities to boost US renewable natural gas productivity
By IPP Bureau - November 14, 2023
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
BioPhy launches AI platform to accelerate the drug development market
By IPP Bureau - November 14, 2023
The company has raised US$4.5 million in funding for its AI operating system
Bayer and Recursion focus research collaboration on Oncology
By IPP Bureau - November 14, 2023
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Narayana Hrudayalaya Q2 FY PAT up at Rs. 226.58 Cr
By IPP Bureau - November 14, 2023
Narayana Hrudayalaya has reported total income of Rs. 1323.64 crores during the period ended September 30, 2023
Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr
By IPP Bureau - November 13, 2023
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr
By IPP Bureau - November 13, 2023
he company posted total income during Q2 FY24 at Rs. 12.86 crore
Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr
By IPP Bureau - November 13, 2023
European operations' revenue grew 58.4% to Rs 599.7 crore
Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr
By IPP Bureau - November 13, 2023
US business grew by +12.8% YoY
Sun Pharma joins hands with WOTR to create water harvesting capacity in Maharashtra
By IPP Bureau - November 13, 2023
This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change
GSK registers 5% revenue growth in Q2 FY24
By IPP Bureau - November 10, 2023
General Medicine grows 5% and Vaccines 10% led by Shingrix
SMS Pharmaceuticals reports robust Q2FY24 operational performance
By IPP Bureau - November 10, 2023
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Intermountain Health files complain against Dr. Reddy’s and others
By IPP Bureau - November 10, 2023
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Aurobindo Pharma posts Q2 FY 24 up 84% at Rs. 752 Cr
By IPP Bureau - November 10, 2023
The company reported net profit after share of profit/loss of JV and minority interest at Rs. 752 crore vs. Rs. 409 crore in Q2FY23
BASF Pharma, IFF Pharma collaborate on virtual assistant platform ZoomLab
By IPP Bureau - November 09, 2023
The collaboration brings a seamless digital experience to more formulators worldwide
Lupin launches Rocuronium Bromide injection in US
By IPP Bureau - November 09, 2023
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
